FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vainutis Vaitkevicius

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Genes & Molecular Sequences

Anatomy

Tumor Cells, Cultured

Co-author Network

Publications

TOP 3
Edgar Ben-Josef; Anthony F Shields; Ulka Nitin Vaishampayan; Vainutis K Vaitkevicius; Basil F El-Rayes; Patrick McDermott; Jay Burmeister; Todd Bossenberger; Philip A Philip
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
Sana Al-Sukhun; Mark M Zalupski; Edgar Ben-Josef; Vainutis K Vaitkevicius; Philip A Philip; Renate Soulen; Donald Willard Weaver; Volkan Adsay; Lance K Heilbrun; Kenneth Levin; Jeffrey D Forman; Anthony F Shields
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Basil F El-Rayes; Anthony F Shields; Vainutis K Vaitkevicius; Philip A Philip
Developments in the systemic therapy of pancreatic cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vainutis Vaitkevicius (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Edgar Ben-Josef; Anthony F Shields; Ulka Nitin Vaishampayan; Vainutis K Vaitkevicius; Basil F El-Rayes; Patrick McDermott; Jay Burmeister; Todd Bossenberger; Philip A Philip
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
International journal of radiation oncology, biology, physics 2004;59(2):454-9.
2003: Sana Al-Sukhun; Mark M Zalupski; Edgar Ben-Josef; Vainutis K Vaitkevicius; Philip A Philip; Renate Soulen; Donald Willard Weaver; Volkan Adsay; Lance K Heilbrun; Kenneth Levin; Jeffrey D Forman; Anthony F Shields
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
American journal of clinical oncology 2003;26(6):543-9.
2003: Basil F El-Rayes; Anthony F Shields; Vainutis K Vaitkevicius; Philip A Philip
Developments in the systemic therapy of pancreatic cancer.
Cancer investigation 2003;21(1):73-86.
2003: Nat L Pernick; Asfar S Azmi; Philip A Philip; Patricia Arlauskas; Anthony F Shields; Vainutis K Vaitkevicius; Michael C Dugan; N Volkan Adsay
Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians.
Pancreas 2003;26(1):28-32.
2002: Ulka Nitin Vaishampayan; Edgar Ben-Josef; Philip A Philip; Vainutis K Vaitkevicius; Wei Du; Kenneth Levin; Anthony F Shields
A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies.
International journal of radiation oncology, biology, physics 2002;53(3):675-9.
2002: Alexey L Glazyrin; Sreenivasa R Chinni; Samir Alhasan; Volkan Adsay; Vainutis K Vaitkevicius; Asfar S Azmi
Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
International journal of oncology 2002;20(1):201-5.
2001: Ramzi M Mohammad; N Volkan Adsay; Philip A Philip; George R Pettit; Vainutis K Vaitkevicius; Asfar S Azmi
Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model.
Anti-cancer drugs 2001;12(9):735-40.
2001: Kambiz Merati; M said Siadaty; Aleodor Andea; Asfar S Azmi; Edgar Ben-Josef; Ramzi M Mohammad; Philip A Philip; Anthony F Shields; Vainutis K Vaitkevicius; David Grignon; N Volkan Adsay
Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.
American journal of clinical oncology 2001;24(5):447-52.
2001: Philip A Philip; Mark M Zalupski; Vainutis K Vaitkevicius; Patricia Arlauskas; Ruth Chaplen; Lance K Heilbrun; Volkan Adsay; Donald Willard Weaver; Anthony F Shields
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.
Cancer 2001;92(3):569-77.
2001: Alexey L Glazyrin; Volkan Adsay; Vainutis K Vaitkevicius; Asfar S Azmi
CD95-related apoptotic machinery is functional in pancreatic cancer cells.
Pancreas 2001;22(4):357-65.
2000: Wei Du; Daniel Touchette; Vainutis K Vaitkevicius; W P Peters; Anthony F Shields
Cost analysis of pancreatic carcinoma treatment.
Cancer 2000;89(9):1917-24.
2000: S Ahmed; Vainutis K Vaitkevicius; Mark M Zalupski; Wei Du; Patricia Arlauskas; C Gordon; C Kellogg; Anthony F Shields
Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
American journal of clinical oncology 2000;23(4):420-4.
2000: Z He; Jeffrey L Evelhoch; Ramzi M Mohammad; N Volkan Adsay; George R Pettit; Vainutis K Vaitkevicius; Asfar S Azmi
Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer.
Pancreas 2000;21(1):69-76.
2000: Volkan Adsay; S Logani; Asfar S Azmi; JD Crissman; Vainutis K Vaitkevicius
Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant.
The American journal of surgical pathology 2000;24(4):493-504.
1999: Ramzi M Mohammad; Yiwei Li; Anwar N Mohamed; George R Pettit; Volkan Adsay; Vainutis K Vaitkevicius; Ayad Al-Katib; Asfar S Azmi
Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
Pancreas 1999;19(4):353-61.
1999: B Gururajanna; Ayad Al-Katib; Y W Li; Olivia Aranha; Vainutis K Vaitkevicius; Asfar S Azmi
Molecular effects of taxol and caffeine on pancreatic cancer cells.
International journal of molecular medicine 1999;4(5):501-7.
1999: N Volkan Adsay; ST Dergham; F C Koppitch; Michael C Dugan; Anwar N Mohamed; Vainutis K Vaitkevicius; Asfar S Azmi
Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.
Pancreas 1999;18(2):111-6.
1999: Yiwei Li; M Bhuiyan; Vainutis K Vaitkevicius; Asfar S Azmi
Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinoma.
Pancreas 1999;18(1):104-10.
1998: Ramzi M Mohammad; Ayad Al-Katib; George R Pettit; Vainutis K Vaitkevicius; US Joshi; Volkan Adsay; Adhip N Majumdar; Asfar S Azmi
An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(4):887-94.
1998: US Joshi; ST Dergham; Yong Q Chen; Michael C Dugan; JD Crissman; Vainutis K Vaitkevicius; Asfar S Azmi
Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus.
Pancreas 1998;16(2):107-13.
1998: Y Li; M Bhuiyan; Vainutis K Vaitkevicius; Asfar S Azmi
Molecular analysis of the p53 gene in pancreatic adenocarcinoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1998;7(1):4-9.
1998: ST Dergham; Michael C Dugan; Asfar S Azmi; Vainutis K Vaitkevicius
Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy.
Journal of hepato-biliary-pancreatic surgery 1998;5(3):269-72.
1998: Mark M Zalupski; Anthony F Shields; Philip A Philip; M Kraut; Patricia M LoRusso; Lance K Heilbrun; Vainutis K Vaitkevicius
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.
Investigational new drugs 1998;16(1):93-6.
1998: Ramzi M Mohammad; Michael C Dugan; Anwar N Mohamed; VP Almatchy; T M Flake; ST Dergham; Anthony F Shields; Ayad Al-Katib; Vainutis K Vaitkevicius; Asfar S Azmi
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.
Pancreas 1998;16(1):19-25.
1997: ST Dergham; Michael C Dugan; US Joshi; Y C Chen; Wei Du; D W Smith; Patricia Arlauskas; JD Crissman; Vainutis K Vaitkevicius; Asfar S Azmi
The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma.
Cancer 1997;80(3):372-81.
1997: ST Dergham; Michael C Dugan; Patricia Arlauskas; Wei Du; Vainutis K Vaitkevicius; JD Crissman; Asfar S Azmi
Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.
International journal of pancreatology : official journal of the International Association of Pancreatology 1997;21(3):225-34.
1997: V Shridhar; S Rivard; X Wang; Ravi Shridhar; C Paisley; Chadwick Mullins; L Beirnat; Michael C Dugan; Asfar S Azmi; OJ Miller; Vainutis K Vaitkevicius; David I Smith
Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer.
Oncogene 1997;14(18):2213-6.
1997: ST Dergham; Michael C Dugan; R Kucway; Wei Du; D S Kamarauskiene; Vainutis K Vaitkevicius; JD Crissman; Asfar S Azmi
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
International journal of pancreatology : official journal of the International Association of Pancreatology 1997;21(2):127-43.
1997: Michael C Dugan; ST Dergham; R Kucway; K Singh; L Biernat; Wei Du; Vainutis K Vaitkevicius; JD Crissman; Asfar S Azmi
HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival.
Pancreas 1997;14(3):229-36.
1996: Ravi Shridhar; V Shridhar; X Wang; W Paradee; Michael C Dugan; Asfar S Azmi; C Wilke; Thomas W Glover; Vainutis K Vaitkevicius; David I Smith
Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors.
Cancer research 1996;56(19):4347-50.
1994: E A Poplin; P S Khanuja; Michael J Kraut; Arnold Herskovic; P B Lattin; G Cummings; Laurie E Gaspar; J L Kinzie; Z Steiger; Vainutis K Vaitkevicius
Chemoradiotherapy of esophageal carcinoma.
Cancer 1994;74(4):1217-24.
1993: N D Nigro; Vainutis K Vaitkevicius; B Considine
Combined therapy for cancer of the anal canal: a preliminary report. 1974.
Diseases of the colon and rectum 1993;36(7):709-11.
1992: Arnold Herskovic; K Martz; M al-Sarraf; L Leichman; J Brindle; Vainutis K Vaitkevicius; J Cooper; R Byhardt; L Davis; B Emami
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.
The New England journal of medicine 1992;326(24):1593-8.
1991: E A Poplin; Michael J Kraut; Laurence H Baker; J Brodfuehrer; Vainutis K Vaitkevicius
A dose-intensive regimen of 5-fluorouracil for the treatment of metastatic colorectal carcinoma.
Cancer 1991;67(2):367-71.
1989: Patricia M LoRusso; R Pazdur; Bruce G Redman; J Kinzie; Vainutis K Vaitkevicius
Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.
American journal of clinical oncology 1989;12(6):486-90.
1989: N D Nigro; Vainutis K Vaitkevicius; B Considine
Dynamic management of squamous cell cancer of the anal canal.
Investigational new drugs 1989;7(1):83-9.
1989: S Huan; R Pazdur; A Singhakowinta; B Samal; Vainutis K Vaitkevicius
Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinoma.
Cancer 1989;63(3):419-22.
1985: Lawrence Leichman; N Nigro; Vainutis K Vaitkevicius; B Considine; T Buroker; G Bradley; H G Seydel; S Olchowski; G Cummings; Cynthia G Leichman
Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy.
The American journal of medicine 1985;78(2):211-5.
1984: L Leichman; Z Steiger; H G Seydel; Vainutis K Vaitkevicius
Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience.
Seminars in oncology 1984;11(2):178-85.
1984: S Martino; B A Samal; A Singhakowinta; S Yoshida; M Mackenzie; J Jain; Vainutis K Vaitkevicius
A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer. Two dose schedules.
Journal of cancer research and clinical oncology 1984;108(3):354-6.
1984: Lawrence Leichman; B McDonald; A Dindogru; M Samson; Vainutis K Vaitkevicius
Cisplatin. An active drug in the treatment of disseminated gastric cancer.
Cancer 1984;53(1):18-22.
1983: N D Nigro; H G Seydel; B Considine; Vainutis K Vaitkevicius; Lawrence Leichman; J J Kinzie
Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal.
Cancer 1983;51(10):1826-9.
1981: Z Steiger; R Franklin; R F Wilson; L Leichman; H Seydel; J J Loh; G Vaishamapayan; T Knechtges; I Asfaw; A Dindogru; J C Rosenberg; T Buroker; A Torres; D Hoschner; P Miller; T Pietruk; Vainutis K Vaitkevicius
Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy, and surgical therapy.
The Journal of thoracic and cardiovascular surgery 1981;82(5):713-9.
1981: A Dindogru; S Pasick; Z Rutkowski; L P Leichman; Vainutis K Vaitkevicius
Total parenteral nutrition in cancer patients.
JPEN. Journal of parenteral and enteral nutrition 1981;5(3):243-5.
1981: N D Nigro; Vainutis K Vaitkevicius; T Buroker; G T Bradley; B Considine
Combined therapy for cancer of the anal canal.
Diseases of the colon and rectum 1981;24(2):73-5.
1981: Z Steiger; R Franklin; R F Wilson; L Leichman; I Asfaw; G Vaishanpayan; J C Rosenberg; J J Loh; A Dindogru; H Seydel; J Hoschner; P Miller; T Knechtges; Vainutis K Vaitkevicius
Complete eradication of squamous cell carcinoma of the esophagus with combined chemotherapy and radiotherapy.
The American surgeon 1981;47(3):95-8.
1981: M L Reed; Vainutis K Vaitkevicius; M Al-Sarraf; C B Vaughn; A Singhakowinta; M Sexon-Porte; R Izbicki; Laurence H Baker; G W Straatsma
The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol.
Cancer 1981;47(2):402-9.
1980: A Singhakowinta; D E Saunders; Sam C Brooks; B Samal; Vainutis K Vaitkevicius
Clinical application of estrogen receptor in breast cancer.
Cancer 1980;46(12 Suppl):2932-8.
1980: Sam C Brooks; D E Saunders; A Singhakowinta; Vainutis K Vaitkevicius
Relation of tumor content of estrogen and progesterone receptors with response of patient to endocrine therapy.
Cancer 1980;46(12 Suppl):2775-8.
1980: B A Samal; Sam C Brooks; G Cummings; L Franco; E A Hire; S Martino; A Singhakowinta; Vainutis K Vaitkevicius
Estrogen receptors and responsiveness of advanced breast cancer to chemotherapy.
Cancer 1980;46(12 Suppl):2925-7.
1980: L P Leichman; Laurence H Baker; C R Stanhope; M K Samson; R J Fraile; Vainutis K Vaitkevicius; R Hilgers
Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot study.
Cancer treatment reports 1980;64(10-11):1139-40.
1980: A Dindogru; S Pasick; Z Rutkowski; B Vinson; Vainutis K Vaitkevicius
Total parenteral nutrition in leukopenic cancer patients.
JAMA : the journal of the American Medical Association 1980;244(7):680-1.
1980: R J Fraile; Laurence H Baker; T R Buroker; Jerome P Horwitz; Vainutis K Vaitkevicius
Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.
Cancer research 1980;40(7):2223-8.